Per Svenningsson

Active 1995–2026

238
Papers
23,641
Citations
88
h-index
216
i10-index

Citations

Citations per year for Per Svenningsson1983: 1 citations1986: 1 citations1991: 2 citations1992: 1 citations1995: 1 citations1996: 3 citations1997: 17 citations1998: 19 citations1999: 50 citations2000: 32 citations2001: 82 citations2002: 67 citations2003: 128 citations2004: 154 citations2005: 146 citations2006: 148 citations2007: 189 citations2008: 187 citations2009: 175 citations2010: 205 citations2011: 289 citations2012: 214 citations2013: 187 citations2014: 146 citations2015: 183 citations2016: 196 citations2017: 180 citations2018: 191 citations2019: 642 citations2020: 677 citations2021: 774 citations2022: 735 citations2023: 603 citations2024: 996 citations2025: 631 citations2026: 30 citations1984–1985: no citations, so these years are not shown1987–1990: no citations, so these years are not shown1993–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,673 citing papers, 23.4% of this breakdownUnited Kingdom: 892 citing papers, 7.8% of this breakdownChina: 828 citing papers, 7.3% of this breakdownSweden: 744 citing papers, 6.5% of this breakdownGermany: 630 citing papers, 5.5% of this breakdownItaly: 630 citing papers, 5.5% of this breakdownFrance: 477 citing papers, 4.2% of this breakdownCanada: 459 citing papers, 4% of this breakdownSpain: 426 citing papers, 3.7% of this breakdownJapan: 262 citing papers, 2.3% of this breakdownNetherlands: 261 citing papers, 2.3% of this breakdownAustralia: 247 citing papers, 2.2% of this breakdown
0%23.4%Other 25.3%

Fields

  • Medicine41.3%
  • Neuroscience27.1%
  • Biochemistry, Genetics and Molecular Biology22%
  • Chemistry3%
  • Psychology1.5%
  • Immunology and Microbiology1%
  • Other4.1%

Topics

  • Parkinson's Disease Mechanisms and Treatments7.8%
  • Neuroscience and Neuropharmacology Research5.3%
  • Neurological disorders and treatments4.5%
  • Neurotransmitter Receptor Influence on Behavior4%
  • Alzheimer's disease research and treatments3.3%
  • Receptor Mechanisms and Signaling3.3%
  • Other71.8%

Coauthors

All papers

Open in search
  1. A multicentre validation study of the diagnostic value of plasma neurofilament light

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , André Strydom, Per Svenningsson, Erik Stomrud, Alexander Santillo, Dag Aarsland, John C. van Swieten, Sebastian Palmqvist, Henrik Zetterberg, Kaj Blennow, Abdul Hye, Oskar Hansson - Nature Communications 2021 cited by 555

  2. Spatial multimodal analysis of transcriptomes and metabolomes in tissues

    Authors: , , , , , , , , , , , , , , , - Nature Biotechnology 2023 cited by 146

  3. The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 140

  4. Vagotomy and Parkinson disease

    Authors: , , , , , , , , - Neurology 2017 cited by 442

  5. A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson's Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Movement Disorders 2023 cited by 82

  6. Depression in Parkinson disease—epidemiology, mechanisms and management

    Authors: , , , , - Nature Reviews Neurology 2011 cited by 586

  7. Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment

    Authors: , , , - The Lancet Neurology 2012 cited by 511

  8. Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Olivier Vanakker, Marja W. Wessels, Suppachok Wetchaphanphesat, Michele Yang, François Boller, Dominique Campion, Didier Hannequin, Marc Sitbon, Daniel H. Geschwind, Jean‐Luc Battini, Giovanni Coppola - Nature Genetics 2015 cited by 316

  9. The noradrenergic subtype of Parkinson disease: from animal models to clinical practice

    Authors: , , , , - Nature Reviews Neurology 2023 cited by 78

  10. Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carmen Dering, Milena Janković, Martin Paucar, Per Svenningsson, Kioomars Saliminejad, Hamid Reza Khorram Khorshid, Ivana Novaković, Adriano Aguzzi, Andreas Boss, Isabelle Le Ber, Gilles Defer, Didier Hannequin, Vladimir S Kostić, Dominique Campion, Daniel H. Geschwind, Giovanni Coppola, Christer Betsholtz, Christine Klein, João Ricardo Mendes de Oliveira - Nature Genetics 2013 cited by 328

  11. An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders

    Authors: , , , , , , , , , , , , , , , , - Nature Reviews Neurology 2020 cited by 196

  12. Comprehensive mapping of neurotransmitter networks by MALDI–MS imaging

    Authors: , , , , , , , , , , , , - Nature Methods 2019 cited by 237

  13. Reduced incidence of Parkinson's disease after dipeptidyl peptidase‐4 inhibitors—A nationwide case‐control study

    Authors: , , , , , , - Movement Disorders 2016 cited by 99

  14. Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson’s disease

    Authors: , , , , , , , , , , , , , , , - Brain 2015 cited by 222

  15. Genome-wide Association Analysis of Parkinson’s Disease and Schizophrenia Reveals Shared Genetic Architecture and Identifies Novel Risk Loci

    Authors: , , , , , , , , , , , , , , , , , , , , , - Biological Psychiatry 2020 cited by 104

  16. Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental parkinsonism in rodents

    Authors: , , , , , , , , , , , , , - Nature Communications 2023 cited by 59

  17. Fixation Duration and Pupil Size as Diagnostic Tools in Parkinson’s Disease

    Authors: , , , , , - Journal of Parkinson s Disease 2021 cited by 59

  18. Spatial lipidomics reveals brain region-specific changes of sulfatides in an experimental MPTP Parkinson’s disease primate model

    Authors: , , , , , , , , - npj Parkinson s Disease 2023 cited by 47

  19. Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s disease

    Authors: , , , , , - Translational Neurodegeneration 2023 cited by 46

  20. Adenosine and Brain Function

    Authors: , , , , - International review of neurobiology 2005 cited by 689

  21. The role of 5-HT1A receptors in learning and memory

    Authors: , , , , , , , , - Behavioural Brain Research 2008 cited by 340

  22. Reduction of spontaneous cortical beta bursts in Parkinson’s disease is linked to symptom severity

    Authors: , , , , , , - Brain Communications 2020 cited by 67

  23. Spatial visualization of comprehensive brain neurotransmitter systems and neuroactive substances by selective in situ chemical derivatization mass spectrometry imaging

    Authors: , , , , , , , , - Nature Protocols 2021 cited by 62

  24. AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine–associated receptor 1

    Authors: , , , , , , , , , , , , , - Science Advances 2024 cited by 51